HIV and highly active antiretroviral therapy: dyslipidemia, metabolic aberrations, and cardiovascular risk.
Zou
Wei
W
Department of Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, University of California School of Medicine, Sacramento, CA 95812, USA.
Berglund
Lars
L
D000163:Acquired Immunodeficiency Syndrome / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism*; D050171:Dyslipidemias / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance; D011506:Proteins / Q000378:metabolism; D012307:Risk Factors
D000596:Amino Acids; D011506:Proteins